NOBILI, ELISABETTA
 Distribuzione geografica
Continente #
AS - Asia 2.384
NA - Nord America 2.369
EU - Europa 1.464
AF - Africa 140
Continente sconosciuto - Info sul continente non disponibili 114
SA - Sud America 104
OC - Oceania 4
Totale 6.579
Nazione #
US - Stati Uniti d'America 2.331
VN - Vietnam 995
SG - Singapore 510
CN - Cina 485
GB - Regno Unito 372
SE - Svezia 180
IT - Italia 174
DE - Germania 165
HK - Hong Kong 135
FR - Francia 108
IN - India 93
RU - Federazione Russa 85
IE - Irlanda 72
NL - Olanda 70
BR - Brasile 69
CH - Svizzera 69
ZA - Sudafrica 41
UA - Ucraina 37
FI - Finlandia 33
JP - Giappone 33
TG - Togo 33
SC - Seychelles 31
EE - Estonia 29
BG - Bulgaria 26
KR - Corea 26
BD - Bangladesh 22
CA - Canada 22
AR - Argentina 17
CI - Costa d'Avorio 16
IQ - Iraq 12
JO - Giordania 12
BE - Belgio 11
NG - Nigeria 11
TH - Thailandia 10
AT - Austria 8
MX - Messico 7
TR - Turchia 7
PH - Filippine 6
EC - Ecuador 5
ID - Indonesia 5
TW - Taiwan 5
AU - Australia 4
CL - Cile 4
IR - Iran 4
JM - Giamaica 4
LT - Lituania 4
SA - Arabia Saudita 4
VE - Venezuela 4
EU - Europa 3
GR - Grecia 3
LB - Libano 3
PK - Pakistan 3
PL - Polonia 3
RO - Romania 3
XK - ???statistics.table.value.countryCode.XK??? 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ES - Italia 2
HR - Croazia 2
KZ - Kazakistan 2
MA - Marocco 2
NP - Nepal 2
PE - Perù 2
PS - Palestinian Territory 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
AG - Antigua e Barbuda 1
BO - Bolivia 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KG - Kirghizistan 1
MU - Mauritius 1
NI - Nicaragua 1
PT - Portogallo 1
RS - Serbia 1
Totale 6.471
Città #
Singapore 351
Southend 327
Ashburn 258
Ho Chi Minh City 254
Chandler 214
Hanoi 195
Fairfield 155
Santa Clara 141
Hong Kong 127
San Jose 122
Dong Ket 112
Wilmington 91
Woodbridge 87
Houston 82
Princeton 80
Seattle 75
Beijing 74
Dublin 72
Ann Arbor 69
Bern 63
Boardman 58
New York 49
Council Bluffs 44
Cambridge 39
Hefei 34
Los Angeles 34
Westminster 34
Lauterbourg 33
Lomé 33
Padova 30
Nanjing 29
Helsinki 28
Sofia 26
Shenyang 24
Bologna 23
Haiphong 23
Tokyo 22
Turin 22
Medford 21
Milan 20
Jacksonville 19
Da Nang 18
Saint Petersburg 17
Abidjan 16
Frankfurt am Main 16
Changsha 15
Hebei 15
Jinan 15
Seoul 15
Shanghai 15
Guangzhou 14
Ha Long 14
San Diego 14
Berlin 13
Buffalo 13
Des Moines 13
Dallas 12
Hải Dương 12
Redondo Beach 12
Abeokuta 11
Amman 11
Brussels 11
Biên Hòa 10
Bắc Giang 10
Florence 10
Nanchang 10
Ninh Bình 10
Thái Nguyên 10
Falls Church 9
Jiaxing 9
Munich 9
Quận Bình Thạnh 9
Redwood City 9
São Paulo 9
Tianjin 9
Zhengzhou 9
Can Tho 8
Hangzhou 8
Kuban 8
Norwalk 8
Vũng Tàu 8
Bắc Ninh 7
Bến Tre 7
Mülheim 7
Orem 7
Quận Một 7
San Francisco 7
Chicago 6
Falkenstein 6
Fremont 6
London 6
Phủ Lý 6
Quận Mười 6
Toronto 6
Brooklyn 5
Johannesburg 5
Monmouth Junction 5
Montreal 5
Paris 5
Phoenix 5
Totale 4.172
Nome #
Vaccine-Based Immunotherapy for Oropharyngeal and Nasopharyngeal Cancers 678
A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor. 232
Venous thromboembolism and port-related thrombosis in metastatic colorectal cancer patients: a monocenter experience. 210
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 207
Autoimmune pancreatitis associated with high levels of chromogranin a, serotonin and 5-hydroxyindoleacetic Acid 193
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis 191
Clinical management of a pituitary gland metastasis from clear cell renal cell carcinoma. 188
Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: A case report within the experience of a single institution 185
Breast carcinoma presenting as linitis plastica 177
Capecitabine(CAP) based regimens vs infusional 5FU/AF in metastatic colorectal cancer cost/effectivness: the differences across the atlantic ocean 177
Advanced pancreatic cancer (APC) A monocenter experience in 53 patients: is it possible a second line treatment? 174
Spontaneous regression of a desmoid intraabdominal tumor in a patient affected by familial adenomatous polyposis. 171
The Protease Inhibitor Gabexate Mesylate Reduces Invasiveness and Angiogenesis in Pancreatic Cancer Cell Lines, Enhancing Gemcitabine Action 168
KRAS and BRAF mutational status as selective criteria for targeted therapy in cholangiocarcinoma. 166
Impact of adjuvant chemotherapy on time to relapse in cholangiocarcinoma. 163
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. 163
Impact of surgery on the development of duodenal cancer in patients with familial adenomatous polyposis. 161
High prevalence of asbestos exposure in bile duct cancer patients 160
Gemox in combination witherlotinib (E) in pancreatic cancer (PC). 160
Advanced pancreatic cancer (apc); a Monocenter experience in 53 patients. It is possible a second line treatment? 159
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOINSTITUTIONAL EXPERIENCE 158
EXOCRINE-ENDOCRINE PANCREATIC CANCER AND alpha-FETOPROTEIN 158
Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? 153
Role of adjuvant chemoradiotherapy (CRT) and chemotherapy alone in pancreatic cancer: experience in 25 patients. 152
Detection of liver lesions during 11C-Choline PET/CT in relapsing prostate cancer patients 152
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible? 149
Effect of the serine proteases inhibitor gabexate mesylate (GM) on the activity of gemcitabine (G) in cell lines of pancreatic cancer (PC) 147
Nanotechnology-Related environment, health and safety Research 137
Systemic adjuvant chemotherapy after resection of colorectal cancer metastases 135
Critical diagnostic delay associated with unusual presentation of hepatocellular carcinoma (Hcc) with orbital metastases: A case report 134
METRONOMIC CAPECITABINE IN HEPATOCELLULAR CARCINOMA RELAPSE AFTER LIVER TRANSPLANTATION: A RETROSPECTIVE STUDY 126
IMPACT OF MULTIDISCIPLINARY APPROACH ON SURVIVAL OF PATIENTS WITH KLATSKIN TUMOR 126
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOISTITUTIONAL EXPERIENCE. 125
THE RISK OF DUODENAL CANCER IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) 124
TO WIDEN THE SETTING OF CANCER PATIENTS WHO BENEFIT FROM METRONOMIC CAPECITABINE 122
The protease inhibitor gabexate Mesylate has antitumor effects and enhances gemcitabine action on pancreatic cancer cell lines 114
Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma 113
PATINUM-BASED CHEMOTHERAPY FOR THE TREATMENT OF HIGH-GRADE GASTROINTESTINAL AND UNKNOWN PRIMARY NEUROENDOCRINE NEOPLASMS 112
Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma 59
Totale 6.579
Categoria #
all - tutte 17.450
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.450


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022673 0 28 26 55 59 42 13 45 44 63 180 118
2022/2023883 85 114 35 100 53 64 25 51 142 40 89 85
2023/2024246 18 28 12 27 19 83 14 22 4 10 4 5
2024/2025795 17 107 72 66 186 45 30 6 8 92 25 141
2025/20262.318 207 560 145 111 223 109 162 56 445 190 61 49
2026/202783 28 55 0 0 0 0 0 0 0 0 0 0
Totale 6.579